Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
See All Experts
featured
Published in Cardiology and
1 other channel

Expert Opinion / Commentary · December 04, 2014

2014 Top Stories in Cardiology: Preventive Cardiology

Paul Thompson MD

 

 Save  Recommend
 Share

Additional Info

  1. CP Cannon on behalf of the IMPROVE IT Investigators. IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes. Paper presented at: AHA Scientific Sessions; November 15-19, 2014; Chicago, IL.

  2. Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. N Engl J Med 2008;358(14):1431-1443.

Disclosure statements are available on the authors' profiles:

Paul Thompson MD

Further Reading

Most Read This Week

Recently Updated